Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.

Ali Z, Din FU, Zahid F, Sohail S, Imran B, Khan S, Malik M, Zeb A, Khan GM

Open source

DOI
10.1186/s40360-022-00625-y
Published
2022 Nov 28
Container
BMC pharmacology & toxicology
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40360-022-00625-y,
  title = {Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.},
  author = {Ali Z and Din FU and Zahid F and Sohail S and Imran B and Khan S and Malik M and Zeb A and Khan GM},
  year = {2022},
  journal = {BMC pharmacology \& toxicology},
  doi = {10.1186/s40360-022-00625-y},
  url = {https://doi.org/10.1186/s40360-022-00625-y}
}

RIS

TY  - JOUR
TI  - Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
AU  - Ali Z
AU  - Din FU
AU  - Zahid F
AU  - Sohail S
AU  - Imran B
AU  - Khan S
AU  - Malik M
AU  - Zeb A
AU  - Khan GM
PY  - 2022
JO  - BMC pharmacology & toxicology
DO  - 10.1186/s40360-022-00625-y
UR  - https://doi.org/10.1186/s40360-022-00625-y
ER  - 

APA

Z, A., FU, D., F, Z., S, S., B, I., S, K., M, M., A, Z., & GM, K. (2022). Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.. BMC pharmacology & toxicology. https://doi.org/10.1186/s40360-022-00625-y

Source records